Status:
COMPLETED
Study of Colorectal Cancer Screening Options
Lead Sponsor:
Kaiser Permanente
Conditions:
Colon Cancer
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
The investigators propose to evaluate Guardant Health's commercially available colorectal cancer screening assay(Guardant SHIELD) in individuals who are not up to date with CRC screening.
Detailed Description
The investigators propose to evaluate Guardant Health's commercially available colorectal cancer screening assay(Guardant SHIELD) in individuals who are not up to date with CRC screening. Primary Obj...
Eligibility Criteria
Inclusion
- Age 45-75
- Received a FIT test in the last 3-9 months yet did not return their FIT
- Upcoming appointment or willing to reschedule an appointment at KPNW within 2 - 6 weeks
- Able and willing to provide informed consent if in the intervention arm
Exclusion
- On KPNW's do not contact list
- Having a legal authorized representative
- Non-English speakers
Key Trial Info
Start Date :
March 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
2004 Patients enrolled
Trial Details
Trial ID
NCT05987709
Start Date
March 17 2022
End Date
June 15 2023
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northwest
Portland, Oregon, United States, 97227